-
Economic Consequences of Disease-Related Malnutrition in Poland and the Potential Cost Savings From Nutritional Interventions: A Two-Step Modeling Study
Sep 9, 2025, 16:22 PM -
Multiple Myeloma Caregiver Costs and Disabilities Data for Economic Modeling and HTA Submissions
Sep 9, 2025, 16:22 PM -
The Economic Value of Self-Administered Subcutaneous Immunoglobulin G (SCIg) in Canada: A Scoping Review
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of Genetic Testing for Optimizing Warfarin Therapy in Mechanical Heart Valve Patients: Insights From Qatar
Sep 9, 2025, 16:22 PM -
Real-World Analysis of Treatment Patterns and Disease Exacerbations Among Patients Initiating Therapy for Myasthenia Gravis
Sep 9, 2025, 16:22 PM -
Evolution in Hospital Bed Capacity in Hungary and Romania Between 1980 and 2020 With Special Focus on Regions Inhabited by Ethnic Minorities
Sep 9, 2025, 16:22 PM -
Baseline Characteristics and Treatment Persistence in UK Patients With Moderate-to-Severe UC Following 12-Week Mirikizumab Induction: Real-World Data From IBD BioResource
Sep 9, 2025, 16:22 PM -
How Does the Source of Transition Probabilities Influence Natural History Simulation and Economic Evaluation in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)?
Sep 9, 2025, 16:22 PM -
Guideline-Driven Off-Label Oncology Use: The Role of Clinical Evidence and Reimbursement Dynamics in the EU4+UK, Switzerland, and Canada
Sep 9, 2025, 16:22 PM -
Systematic Review of Prognostic Factors for Efficacy and Safety Outcomes in CAR-T Cell Therapy for Diffuse Large B-cell Lymphoma
Sep 9, 2025, 16:22 PM -
Operational and Economic Impact of CLL Treatment Regimens: Insights From a Multidisciplinary Study in Portugal
Sep 9, 2025, 16:22 PM -
Clinical Utility of Multiplex Point of Care (PCR) Compared to Antigen Testing for Influenza-Like Illness in the Hospital Emergency Department
Sep 9, 2025, 16:22 PM -
Patients’ Advocacy Groups in Italy: An Updated Perspective on Activities and Future Directions
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of RefluxStop for Treatment of Chronic Gastro-esophageal Reflux Disease: A US Medicare Perspective
Sep 9, 2025, 16:22 PM -
Real-World Adherence to Nonhormonal Therapies for Menopause-Related Vasomotor Symptoms: A Targeted Literature Review
Sep 9, 2025, 16:22 PM -
Patterns of Treatment Adherence and Administration Preferences for People With Transthyretin Amyloid Cardiomyopathy: A Real-World Survey in Europe, the United States, and Japan
Sep 9, 2025, 16:22 PM -
A Health Economic Evaluation of Daylight: A Digital Treatment for Anxiety in NHS South Yorkshire
Sep 9, 2025, 16:22 PM -
Real-World Evidence (RWE) and Its Impact on Scottish Medicines Consortium (SMC) Decisions: A Retrospective Review
Sep 9, 2025, 16:22 PM -
Assessment of the Inclusion and Importance of Carer Quality of Life in Global Health Technology Appraisals
Sep 9, 2025, 16:22 PM -
Assessment Of Parental Knowledge Information-Seeking and Information-Providing Regarding Newborn And Infant Screening Examinations
Sep 9, 2025, 16:22 PM
